$7.74
0.111.44%
In chiusura: -
$7.61
-0.13-1.68%
After hour: Oct 3, 7:38 PM EDT
Comments
Loading...
Monte Rosa Therapeutics Rapporto sugli interessi allo scoperto
GLUENASDAQ
Report sulle vendite allo scoperto
Il short interest su Monte Rosa Therapeutics Inc (NASDAQ:GLUE) è diminuito durante l'ultimo periodo di rilevazione, aumentando da 8.24M a 8.24M. Questo rappresenta il 17.67% delle azioni disponibili pubblicamente dell'azienda.
L'interesse allo scoperto in Monte Rosa Therapeutics Corp (XNAS:GLUE) è diminuito durante l'ultimo periodo di rendicontazione, passando da 280,30 milioni a 275,20 milioni. Ciò ha portato allo scoperto l'1,17% delle azioni pubbliche della società.
Sulla base del volume medio recente di 3.44M azioni scambiate al giorno, ci vorrebbero 2.4 giorno(i) per chiudere le posizioni di questo interesse a breve senza spingere fortemente al rialzo il titolo.
Vendite allo scoperto
8.24M
Vendite allo scoperto %
17.7%
Giorni di copertura
2.4
Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|
GLUE | Monte Rosa Therapeutics, Inc. | 09/15/2025 | 09/24/2025 | 17.67% | 46,629,137 | 8,239,631 | 3,435,778 | 2.4 | |
GLUE | Monte Rosa Therapeutics, Inc. | 08/29/2025 | 09/10/2025 | 17.67% | 46,629,137 | 8,241,602 | 329,775 | 24.99 | |
GLUE | Monte Rosa Therapeutics, Inc. | 08/15/2025 | 08/26/2025 | 17.85% | 46,629,137 | 8,321,153 | 410,919 | 20.25 | |
GLUE | Monte Rosa Therapeutics, Inc. | 07/31/2025 | 08/11/2025 | 18.66% | 46,629,137 | 8,701,757 | 482,728 | 18.03 | |
GLUE | Monte Rosa Therapeutics, Inc. | 07/15/2025 | 07/24/2025 | 19.23% | 46,379,608 | 8,919,776 | 376,500 | 23.69 | |
GLUE | Monte Rosa Therapeutics, Inc. | 06/30/2025 | 07/10/2025 | 19.11% | 46,379,608 | 8,862,358 | 471,584 | 18.79 | |
GLUE | Monte Rosa Therapeutics, Inc. | 06/13/2025 | 06/25/2025 | 19.13% | 46,379,608 | 8,872,105 | 443,486 | 20.01 | |
GLUE | Monte Rosa Therapeutics, Inc. | 05/30/2025 | 06/10/2025 | 17.41% | 46,379,608 | 8,075,031 | 491,115 | 16.44 | |
GLUE | Monte Rosa Therapeutics, Inc. | 05/15/2025 | 05/27/2025 | 18.10% | 46,379,608 | 8,395,716 | 361,835 | 23.2 | |
GLUE | Monte Rosa Therapeutics, Inc. | 04/30/2025 | 05/09/2025 | 16.98% | 46,379,608 | 7,876,484 | 532,316 | 14.8 | |
GLUE | Monte Rosa Therapeutics, Inc. | 04/15/2025 | 04/25/2025 | 16.32% | 46,165,981 | 7,532,066 | 1,082,912 | 6.96 | |
GLUE | Monte Rosa Therapeutics, Inc. | 03/31/2025 | 04/09/2025 | 11.73% | 46,165,981 | 5,414,033 | 996,914 | 5.43 | |
GLUE | Monte Rosa Therapeutics, Inc. | 03/14/2025 | 03/25/2025 | 15.24% | 46,165,981 | 7,033,824 | 629,113 | 11.18 | |
GLUE | Monte Rosa Therapeutics, Inc. | 02/28/2025 | 03/11/2025 | 23.91% | 33,631,342 | 8,042,209 | 421,752 | 19.07 | |
GLUE | Monte Rosa Therapeutics, Inc. | 02/14/2025 | 02/26/2025 | 23.87% | 33,631,342 | 8,029,011 | 374,506 | 21.44 | |
GLUE | Monte Rosa Therapeutics, Inc. | 01/31/2025 | 02/11/2025 | 24.01% | 33,631,342 | 8,074,830 | 757,814 | 10.66 | |
GLUE | Monte Rosa Therapeutics, Inc. | 01/15/2025 | 01/27/2025 | 26.04% | 33,631,342 | 8,755,986 | 1,175,120 | 7.45 | |
GLUE | Monte Rosa Therapeutics, Inc. | 12/31/2024 | 01/10/2025 | 27.19% | 33,631,342 | 9,144,923 | 1,328,106 | 6.89 | |
GLUE | Monte Rosa Therapeutics, Inc. | 12/13/2024 | 12/24/2024 | 24.99% | 33,631,342 | 8,404,331 | 2,277,630 | 3.69 | |
GLUE | Monte Rosa Therapeutics, Inc. | 11/29/2024 | 12/10/2024 | 32.87% | 33,631,342 | 11,054,976 | 849,203 | 13.02 | |
GLUE | Monte Rosa Therapeutics, Inc. | 11/15/2024 | 11/26/2024 | 33.16% | 33,631,342 | 11,152,201 | 1,285,572 | 8.67 | |
GLUE | Monte Rosa Therapeutics, Inc. | 10/31/2024 | 11/11/2024 | 23.31% | 33,631,342 | 7,837,789 | 8,722,587 | 1 | |
GLUE | Monte Rosa Therapeutics, Inc. | 10/15/2024 | 10/24/2024 | 15.59% | 33,567,426 | 5,232,009 | 739,503 | 7.08 | |
GLUE | Monte Rosa Therapeutics, Inc. | 09/30/2024 | 10/09/2024 | 13.04% | 33,567,426 | 4,377,009 | 502,669 | 8.71 | |
GLUE | Monte Rosa Therapeutics, Inc. | 09/13/2024 | 09/24/2024 | 9.75% | 33,567,426 | 3,273,659 | 232,187 | 14.1 | |
GLUE | Monte Rosa Therapeutics, Inc. | 08/30/2024 | 09/11/2024 | 9.12% | 33,567,426 | 3,061,103 | 256,199 | 11.95 | |
GLUE | Monte Rosa Therapeutics, Inc. | 08/15/2024 | 08/26/2024 | 8.31% | 33,567,426 | 2,790,585 | 179,205 | 15.57 | |
GLUE | Monte Rosa Therapeutics, Inc. | 07/31/2024 | 08/09/2024 | 8.34% | 33,345,097 | 2,779,929 | 199,147 | 13.96 | |
GLUE | Monte Rosa Therapeutics, Inc. | 07/15/2024 | 07/24/2024 | 8.58% | 33,345,097 | 2,862,510 | 254,288 | 11.26 | |
GLUE | Monte Rosa Therapeutics, Inc. | 06/28/2024 | 07/10/2024 | 7.68% | 33,345,097 | 2,559,406 | 322,239 | 7.94 | |
GLUE | Monte Rosa Therapeutics, Inc. | 06/14/2024 | 06/26/2024 | 5.94% | 33,345,097 | 1,980,933 | 236,241 | 8.39 | |
GLUE | Monte Rosa Therapeutics, Inc. | 05/31/2024 | 06/11/2024 | 5.71% | 33,345,097 | 1,905,042 | 298,781 | 6.38 | |
GLUE | Monte Rosa Therapeutics, Inc. | 05/15/2024 | 05/24/2024 | 6.93% | 33,345,097 | 2,311,172 | 148,551 | 15.56 | |
GLUE | Monte Rosa Therapeutics, Inc. | 04/30/2024 | 05/09/2024 | 8.43% | 22,706,621 | 1,914,927 | 108,964 | 17.57 | |
GLUE | Monte Rosa Therapeutics, Inc. | 04/15/2024 | 04/24/2024 | 8.29% | 22,519,926 | 1,866,469 | 133,774 | 13.95 | |
GLUE | Monte Rosa Therapeutics, Inc. | 03/28/2024 | 04/09/2024 | 6.25% | 26,932,207 | 1,684,402 | 180,200 | 9.35 | |
GLUE | Monte Rosa Therapeutics, Inc. | 03/15/2024 | 03/26/2024 | 6.78% | 26,932,207 | 1,827,198 | 125,793 | 14.53 | |
GLUE | Monte Rosa Therapeutics, Inc. | 02/29/2024 | 03/11/2024 | 6.84% | 26,932,207 | 1,842,447 | 121,547 | 15.16 | |
GLUE | Monte Rosa Therapeutics, Inc. | 02/15/2024 | 02/27/2024 | 7.36% | 26,859,157 | 1,977,330 | 138,039 | 14.32 | |
GLUE | Monte Rosa Therapeutics, Inc. | 01/31/2024 | 02/09/2024 | 7.12% | 26,859,157 | 1,911,930 | 122,859 | 15.56 | |
GLUE | Monte Rosa Therapeutics, Inc. | 01/12/2024 | 01/24/2024 | 7.30% | 26,859,157 | 1,961,063 | 229,780 | 8.53 | |
GLUE | Monte Rosa Therapeutics, Inc. | 12/29/2023 | 01/10/2024 | 7.66% | 26,859,157 | 2,058,086 | 243,493 | 8.45 | |
GLUE | Monte Rosa Therapeutics, Inc. | 12/15/2023 | 12/27/2023 | 8.78% | 26,859,157 | 2,358,012 | 348,294 | 6.77 | |
GLUE | Monte Rosa Therapeutics, Inc. | 11/30/2023 | 12/11/2023 | 11.06% | 26,859,157 | 2,971,603 | 184,633 | 16.09 | |
GLUE | Monte Rosa Therapeutics, Inc. | 11/15/2023 | 11/27/2023 | 11.38% | 26,859,157 | 3,057,272 | 209,944 | 14.56 | |
GLUE | Monte Rosa Therapeutics, Inc. | 10/31/2023 | 11/09/2023 | 12.66% | 26,437,472 | 3,347,452 | 596,626 | 5.61 | |
GLUE | Monte Rosa Therapeutics, Inc. | 10/13/2023 | 10/24/2023 | 14.11% | 26,437,472 | 3,729,692 | 183,016 | 20.38 | |
GLUE | Monte Rosa Therapeutics, Inc. | 09/29/2023 | 10/10/2023 | 15.14% | 26,437,472 | 4,002,277 | 165,793 | 24.14 |
In cerca di azioni più vendute allo scoperto?